KMKamada Ltd. KMDA · NASDAQ
$7.73 -0.64% (-$0.05)
- Market cap
- $446.0M
- Enterprise value
- $428.3M
- P/E
- 20.0x
- Forward P/E
- 16.3x
- PEG
- 0.6x
- P/S
- 2.3x
- P/FCF
- 16.8x
- EV/EBITDA
- 10.2x
- ROIC
- 6.9%
- Gross margin
- 40.8%
- Net margin
- 11.6%
- Dividend yield
- 5.43%
- Payout ratio
- 108.9%
- Net debt/EBITDA
- -0.4x
- Beta
- 0.13
- Free float
- 54.9%
About the company
Kamada Ltd. (KMDA) is a biopharmaceutical company engaged in research, development, and manufacturing of therapeutic products. The company specializes in the development and production of protein therapeutics and immunoglobulins for various therapeutic applications. Kamada has developed a range of biological therapeutics and products aimed at treating rare and genetic diseases, including immune deficiencies and hematological disorders. With its innovative products and meticulous research, the company maintains a significant position in the biopharmaceutical sector. Kamada Ltd. (KMDA) also has extensive collaborations with international pharmaceutical companies for the distribution of its therapeutics and the development of new treatment possibilities. Kamada Ltd. (KMDA) shares may be an attractive investment opportunity for investors interested in the biopharmaceutical sector and seeking an investment in a company with an innovative portfolio of therapeutics and potential for further growth in treatment technologies.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Amir London
Employees
462
Headquarters
Rehovot
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number